Catalyst Wire Dossier Catalyst Wire Dossier

Transcutaneous auricular vagus nerve stimulation device

transcutaneous auricular vagus nerve stimulation
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Transcutaneous auricular vagus nerve stimulation device, covering 2025-12-31 to 2026-04-24. Get the full timeline:

Most recent: Clinical Trial Update: Transcutaneous Auricular Vagus Nerve Stimulation for Insomnia in Survivors of Childhood Acute Lymphoblastic Leukemia [NA]

See pricing